The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-4329
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2026
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Shishkova V.N.

National Medical Research Center for Therapy and Preventive Medicine Federal State Budgetary Institution the Ministry of Health of Russia;
A.I. Yevdokimov Moscow State University of Medicine and Dentistry Federal State Budgetary Educational Institution of Higher Education

Engaging the brain

Authors:

Shishkova V.N.

More about the authors

Journal: Non Nocere. New Therapeutic Journal. 2024;(5): 64‑68

Read: 463 times

Download PDF (RU)
Contact the author
Table of contents

To cite this article:

Shishkova VN. Engaging the brain. Non Nocere. New Therapeutic Journal. 2024;(5):64‑68. (In Russ.)

МСФ на ЯМ
Использование инфографики авторами научных работ
Close metadata
Abstract:

Autonomic dysfunction in patients with cerebrovascular disease and metabolic syndrome.

Authors:

Shishkova V.N.

National Medical Research Center for Therapy and Preventive Medicine Federal State Budgetary Institution the Ministry of Health of Russia;
A.I. Yevdokimov Moscow State University of Medicine and Dentistry Federal State Budgetary Educational Institution of Higher Education

Close metadata

References:

  1. Vegetative disorders (clinic, diagnosis, treatment) / edited by A.M. Vein. Moscow: Medical Information Agency, 1998. – P. 752. 
  2. Demidova T.Yu. Metabolic syndrome. Basics of diagnosis, pathogenesis, clinical manifestations and ways of correction // In book Ametov A.S. (ed.) Selected Lectures on Endocrinology. – M.: MIA, 2009. – Pp. 129-155. 
  3. Grassi G. Sympathetic overdrive and cardiovascular risk in the metabolic syndrome. Hypertens Res. 2006 Nov;29(11):839-847.  https://doi.org/10.1291/hypres.29.839
  4. Lambert E, Straznicky N, Sari CI, et al. Dyslipidemia is associated with sympathetic nervous activation and impaired endothelial function in young females. Am J Hypertens. 2013 Feb;26(2):250-256.  https://doi.org/10.1093/ajh/hps016
  5. Carlyle M, Jones OB, Kuo JJ, Hall JE. Chronic cardiovascular and renal actions of leptin: role of adrenergic activity. Hypertension. 2002 Feb;39(2 Pt 2):496-501.  https://doi.org/10.1161/hy0202.104398
  6. Julius S, Nesbitt SD. Sympathetic nervous system as a coronary risk factor in hypertension. Cardiologia. 1996 Apr;41(4):309-317. 
  7. Kaye DM, Lefkovits J, Jennings GL, Bergin P, Broughton A, Esler MD. Adverse consequences of high sympathetic nervous activity in the failing human heart. J Am Coll Cardiol. 1995 Nov 1;26(5):1257-1263. https://doi.org/10.1016/0735-1097(95)00332-0
  8. Lai CL, Lin RT, Liou LM, Hsu CY, Hsieh HY, Liu CK. The effects of metabolic syndrome and apolipoprotein E4 on cognitive event-related potentials. Biol Psychol. 2010 Jan;83(1):56-61.  https://doi.org/10.1016/j.biopsycho.2009.10.004
  9. Lambert E, Sari CI, Dawood T, et al. Sympathetic nervous system activity is associated with obesity-induced subclinical organ damage in young adults. Hypertension. 2010 Sep;56(3):351-358.  https://doi.org/10.1161/HYPERTENSIONAHA.110.155663
  10. Masuo K, Mikami H, Ogihara T, Tuck ML. Sympathetic nerve hyperactivity precedes hyperinsulinemia and blood pressure elevation in a young, nonobese Japanese population. Am J Hypertens. 1997 Jan;10(1):77-83.  https://doi.org/10.1016/s0895-7061(96)00303-2
  11. Mychka V.B. Excess body weight and hypertension. Consilium Medicum. 2005;3(5):25-26. 
  12. Straznicky NE, Lambert GW, Masuo K, et al. Blunted sympathetic neural response to oral glucose in obese subjects with the insulin-resistant metabolic syndrome. Am J Clin Nutr. 2009 Jan;89(1):27-36.  https://doi.org/10.3945/ajcn.2008.26299
  13. Weil BR, Stauffer BL, Mestek ML, DeSouza CA. Influence of abdominal obesity on vascular endothelial function in overweight/obese adult men. Obesity (Silver Spring). 2011 Sep;19(9):1742-1746. https://doi.org/10.1038/oby.2011.189
  14. Drexler H, Hayoz D, Münzel T, et al. Endothelial function in chronic congestive heart failure. Am J Cardiol. 1992 Jun 15;69(19):1596-1601. https://doi.org/10.1016/0002-9149(92)90710-g
  15. Haynes WG, Morgan DA, Walsh SA, Mark AL, Sivitz WI. Receptor-mediated regional sympathetic nerve activation by leptin. J Clin Invest. 1997 Jul 15;100(2):270-278.  https://doi.org/10.1172/JCI119532
  16. Trayhurn P, Beattie JH. Physiological role of adipose tissue: white adipose tissue as an endocrine and secretory organ. Proc Nutr Soc. 2001 Aug;60(3):329-339.  https://doi.org/10.1079/pns200194
  17. Van Harmelen V, Reynisdottir S, Eriksson P, et al. Leptin secretion from subcutaneous and visceral adipose tissue in women. Diabetes. 1998 Jun;47(6):913-917.  https://doi.org/10.2337/diabetes.47.6.913
  18. Bartness TJ, Bamshad M. Innervation of mammalian white adipose tissue: implications for the regulation of total body fat. Am J Physiol. 1998 Nov;275(5): R1399-13411. https://doi.org/10.1152/ajpregu.1998.275.5.R1399
  19. Loffreda S, Yang SQ, Lin HZ, et al. Leptin regulates proinflammatory immune responses. FASEB J. 1998 Jan;12(1):57-65. 
  20. Skoromets A.A. Somatoneurology: a guide for doctors. - SPb.: SpetsLit, 2009. – 655 p. 
  21. Tesfaye S, Boulton AJ, Dyck PJ, et al. Diabetic neuropathies: update on definitions, diagnostic criteria, estimation of severity, and treatments. Diabetes Care. 2010 Oct;33(10):2285-2293. https://doi.org/10.2337/dc10-1303
  22. Levin O.S. Polyneuropathies: Clinical Manual. – Moscow: LLC “Publishing House ‘Medical Information Agency’, 2011. – 496 p. 
  23. Vorobyev S.V., Kirichenko D.A., Palenyi A.I., Karakhanyan K.S. Diagnostics and treatment of vegetative dysfunction in patients with metabolic syndrome and carbohydrate metabolism disorders. Treating physician. Cardiology. 2009;1:64-66. 
  24. Vein A.M., Solovieva A.D., Kolosova O.A.. Vegetovascular dystonia. – Moscow: Medicine, 1981. – 318 p. 
  25. Nalbat A.V., Yakupov E.Z., Huzyasheva E.I. Vegetative dysfunction syndrome in various forms of cerebral vascular pathology. Neurologicheskiy vestnik. 2012;44(3):100-108. 
  26. Boldina N.V., Mikhin V.P., Chernyatina M.A., Vodyanik O.V. Effect of mexicor on heart rate variability and daily profile of blood pressure in patients with ischemic stroke on the background of arterial hypertension. Kursk Scientific and Practical Bulletin “Man and Health”. 2008;2:39-47. 
  27. Fonyakin A.V., Samokhvalova E.V., Geraskina L.A. Vegetative regulation of the heart and the risk of cardiac complications in ischemic stroke. Praktichna angiologia. 2008;5(16):26-30. 
  28. Mikhailov V.M. Heart rate variability. Experience of practical application. - Ivanovo: Ivan. gos. med. academy, 2000. – 200 p. 
  29. Doux JD, Yun AJ. The link between carotid artery disease and ischemic stroke may be partially attributable to autonomic dysfunction and failure of cerebrovascular autoregulation triggered by Darwinian maladaptation of the carotid baroreceptors and chemoreceptors. Med Hypotheses. 2006;66(1):176-181.  https://doi.org/10.1016/j.mehy.2005.03.016
  30. Shishkova VN, Adasheva TV. Cerebrovascular disease in patients with type 2 diabetes mellitus. S.S. Korsakov Journal of Neurology and Psychiatry. 2021;121(6):114-118. (In Russ.). https://doi.org/10.17116/jnevro2021121061114
  31. Shalashova M.L., Dudaeva N.G., Golovacheva T.V. Use of Mexidol in combined therapy with traditional antihypertensive agents in patients with arterial hypertension with signs of chronic cerebral vascular insufficiency. Bulletin of experimental biology and medicine. 2006;1(7):152-155. 
  32. Dyakonova EN, Makerova VV. Mono- and combination therapy with the mexidol in young patients with cerebral angiodystonia. S.S. Korsakov Journal of Neurology and Psychiatry. 2018;118(8):52-60. (In Russ.). https://doi.org/10.17116/jnevro201811808152
  33. Sergienko M.E. Clinical experience of using the drug Mexidol for correction of astheno-vegetative disorders in patients with mild craniocerebral trauma. Pharmateca. 2012;19:27-31. 
  34. Vorsin L.P. EEG and HRV indices in patients with dysfunction of suprasegmental departments of the autonomic nervous system: experience of using Mexidol. Bulletin of experimental biology and medicine. 2012;(appendix 1):172-176. 
  35. Yanishevskiy S.N. Experience of using the drug Mexidol in the treatment of chronic insufficiency of cerebral circulation in patients with stenosing-occlusive lesion of the main brachycephalic vessels. Bulletin of Experimental Biology and Medicine. 2006;5(1):159-163. 
  36. Antipenko EA, Derugina AV, Gustov AV. The system stress-limiting action of mexidol in chronic cerebral ischemia. S.S. Korsakov Journal of Neurology and Psychiatry. 2016;116(4):28-31. (In Russ.). https://doi.org/10.17116/jnevro20161164128-31
  37. Antipenko E.A. Adaptogenic effects of mexidol in chronic cerebral ischemia. S.S. Korsakov Journal of Neurology and Psychiatry. 2012;112(3):44-49. (In Russ.).
  38. Fedin AI, Zaharov VV, Tanashyan MM, Chukanova EI, Madzhidova EN, Shchepankevich LA, Ostroumova OD. Results of an international multicenter, randomized, double-blind, placebo-controlled study assessing the efficacy and safety of sequential therapy with Mexidol and Mexidol FORTE 250 in patients with chronic brain ischemia (MEMO). S.S. Korsakov Journal of Neurology and Psychiatry. 2021;121(11):7-16. (In Russ.). https://doi.org/10.17116/jnevro20211211117
Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.